Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms clinical trials

Explore recruiting acute myeloid leukemia secondary to myeloproliferative neoplasms clinical trials.

Recruiting acute myeloid leukemia secondary to myeloproliferative neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, prospective, multi-center intervention trial in patients with acute myeloid leukemia secondary to myeloproliferative neoplasms unfit for intensive chemotherapy investigating a treatment combination including decitabine and venetoclax. ENABLE (vENetoclax plus decitAbine treatment in Blastic phase of myeLoproliferative nEoplasms). AML2420

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms trials by city

Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Toronto Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Vancouver Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Montreal Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Calgary Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Edmonton Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Ottawa Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Winnipeg Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Quebec City Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Hamilton Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Kitchener Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in London Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Halifax Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in New York Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Los Angeles Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Chicago Acute Myeloid Leukemia Secondary To Myeloproliferative Neoplasms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease